Tag : 1b

Pharma / Biotech

Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial.

Newsemia
Related Articles Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Lancet Oncol. 2019...
Latest News

ImmunoGen Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination with Carboplatin and Avastin® at ESMO

Newsemia
WALTHAM, Mass.–(BUSINESS WIRE)–IMGN Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab in Combination with Carboplatin and Avastin® at ESMO Source link...
Neurology

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

Newsemia
Congratulations Dr. Nikolaus McFarland on the publication of “Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose...
Latest News

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Newsemia
Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer’s Disease meeting, in Barcelona, Spain, from the recent 36-...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy